These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6431716)

  • 21. Animal models of M. tuberculosis Infection.
    Orme I; Gonzalez-Juarrero M
    Curr Protoc Microbiol; 2007 Nov; Chapter 10():Unit 10A.5. PubMed ID: 18770606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathomorphological characteristics of tuberculosis in relation to the variability of the causative agent].
    Puzik VI; Zemskova ZS; Dorozhkova IR; Nurusheva AM
    Probl Tuberk; 1981 Jul; (7):50-4. PubMed ID: 6792629
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of different chemotherapy regimens with pulmonary tuberculosis patients based on the data from a comprehensive bacteriological study].
    Muratov VV; Pashkov IuN; Chukanov VI
    Probl Tuberk; 1983 May; (5):34-8. PubMed ID: 6408636
    [No Abstract]   [Full Text] [Related]  

  • 24. The pulmonary tuberculous lesion in North India: a study in medico-legal autopsies. II. Bacteriologic aspects.
    Bhathena D; Mohapatra LN; Mital GS; Ramalingaswami V; Nayak NC
    Am Rev Respir Dis; 1970 Jan; 101(1):18-26. PubMed ID: 4983002
    [No Abstract]   [Full Text] [Related]  

  • 25. [The virulence of Mycobacterium tuberculosis isolated from the sputum and bronchial secretion of patients with specific forms of pulmonary tuberculosis].
    Szelerska-Twardosz H
    Pneumonol Pol; 1988 Mar; 56(3):106-10. PubMed ID: 3136445
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biological characteristics of M. tuberculosis and difficulties in microbiological diagnosis of tuberculosis].
    Golyshevskaia VI; Korneev AA; Chernousova LN; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (2):30-2. PubMed ID: 7777459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The morphological reactions in the lungs during the chemotherapy of experimental tuberculosis].
    Erokhin VV
    Probl Tuberk; 2000; (5):15-9. PubMed ID: 11077845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The significance of L-form mycobacteria in the development of pulmonary tuberculosis].
    Snitinskaia OS; Sibirnaia RI; Beliakova OI
    Vrach Delo; 1990 Mar; (3):38-40. PubMed ID: 2114701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of casual isolation of acid-fast organisms from sputum of tuberculous patients.
    Tsukamura M
    Am Rev Respir Dis; 1973 Dec; 108(6):1429-30. PubMed ID: 4201631
    [No Abstract]   [Full Text] [Related]  

  • 30. [Estimation of the degree of risk of reactivation of residual tuberculous changes based on the status of mycobacterial population].
    Krudu VN; Dorozhkova IR
    Probl Tuberk; 1992; (5-6):45-7. PubMed ID: 1409517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumonia caused by Mycobacterium tuberculosis.
    Wei M; Yongjie Zhao ; Zhuoyu Qian ; Biao Yang ; Xi J; Wei J; Tang B
    Microbes Infect; 2020; 22(6-7):278-284. PubMed ID: 32561408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Morphological signs of inflammatory activity in different clinical forms of drug-resistant pulmonary tuberculosis].
    Elipashev AA; Nikolsky VO; Shprykov AS
    Arkh Patol; 2017; 79(4):13-17. PubMed ID: 28791993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical efficiency of combined chemotherapy of patients with progressive forms of pulmonary tuberculosis].
    Cheren'ko SO
    Lik Sprava; 2001; (1):76-80. PubMed ID: 15311700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tubercle bacilli retain pathogenicity after seven weeks chemotherapy.
    Cassidy JT
    Med J Aust; 1981 May; 1(11):588-9. PubMed ID: 6789046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The treatment of tuberculosis. I. Mycobacterial subpopulations in the lesions and antitubercular drugs].
    Corlan E
    Pneumoftiziologia; 1992; 41(4):231-42. PubMed ID: 1339503
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dynamics of isolation of mycobacterium tuberculosis during 2-stage standard chemotherapy].
    Khomenko AG; Vasil'eva IA
    Probl Tuberk; 1996; (6):52-4. PubMed ID: 9019772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Morphologic and biochemical changes in Mycobacterium tuberculosis during chemotherapy].
    Khomenko AG; Fadeeva NI; Golyshevskaia VI
    Probl Tuberk; 1983 Jul; (7):48-54. PubMed ID: 6415652
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of the "open-negative syndrome in the clinical course of tuberculosis].
    Elemanov MG; Kharcheva KA; Vavillin GI
    Probl Tuberk; 1974; 52(6):19-23. PubMed ID: 4211436
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the morphological diagnosis of drug-resistant pulmonary tuberculosis].
    Ziuzia IuR; Lepekha LN; Gedymin LE; Burtseva SA; Erokhin VV
    Probl Tuberk Bolezn Legk; 2006; (10):56-60. PubMed ID: 17139834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dynamics of bacterial populations in experimental destructive pulmonary tuberculosis under treatment].
    Golişevskaia V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(2):111-4. PubMed ID: 6264575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.